About Zinc finger protein 77
Zinc finger protein 77 (ZNF77) is a protein
from Homo sapiens identified by UniProt accession
Q15935, 545 residues long.
MolForge cross-references it against 0 known binders and
92 disease associations.
Target properties
| Protein name | Zinc finger protein 77 |
| UniProt accession | Q15935 |
| Gene | ZNF77 |
| Organism | Homo sapiens |
| Length | 545 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (92)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.24
- neoplasm · score 0.07
- chronic kidney disease · score 0.03
- juvenile idiopathic arthritis · score 0.01
- myocardial infarction · score 0.01
- retinal degeneration · score 0.01
- systemic juvenile idiopathic arthritis · score 0.01
- acute kidney failure · score 0.01
- cancer · score 0.01
- infection · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15935-F1 | alphafold | PREDICTED | 68.24 | — |
Amino-acid sequence (545 residues)
MDCVIFEEVA VNFTPEEWAL LDHAQRSLYR DVMLETCRNL ASLDCYIYVR TSGSSSQRDV FGNGISNDEE IVKFTGSDSW SIFGENWRFD NTGDQHQIPQ RHLRSQLGRL CESNEGHQCG ETLSQTANLL VHKSYPTEAK PSECTKCGKA FENRQRSHTG QRPCKECGQA CSCLSCQSPP MKTQTVEKPC NCQDSRTASV TYVKSLSSKK SYECQKCGKA FICPSSFRGH VNSHHGQKTH ACKVCGKTFM YYSYLTRHVR THTGEKPYEC KECGKAFSCP SYFREHVRTH TGEKPYECKH CGKSFSCYSS FRDHVRTHTG EKPCQCKHCG KAFTCYSSLR EHGRTHSGEK PYECKECGKA FRYPSSLRAH MRMHTGEKPY VCKQCGKAFG CPTYFRRHVK THSGVKPYQC KECGKAYSFS SSLRIHVRTH TGEKPFECKH CGKAFSCHSS LREHVRTHSG EKPYECNQCG KAFSHAQYFQ KHVRSHSGVK PYECTECGKA YSCSSSLRVH VRTHTGERPY ECKQCGKTFR YLASLQAHVR THAGA
Explore Zinc finger protein 77 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets